Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 264

1.

Role of Chemokines in Thyroid Cancer Microenvironment: Is CXCL8 the Main Player?

Rotondi M, Coperchini F, Latrofa F, Chiovato L.

Front Endocrinol (Lausanne). 2018 Jun 21;9:314. doi: 10.3389/fendo.2018.00314. eCollection 2018. Review.

2.

Antithyroid drug treatment for Graves' disease: baseline predictive models of relapse after treatment for a patient-tailored management.

Masiello E, Veronesi G, Gallo D, Premoli P, Bianconi E, Rosetti S, Cusini C, Sabatino J, Ippolito S, Piantanida E, Tanda ML, Chiovato L, Wiersinga WM, Bartalena L.

J Endocrinol Invest. 2018 Jun 26. doi: 10.1007/s40618-018-0918-9. [Epub ahead of print]

PMID:
29946800
3.

Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients.

Teliti M, Cogni G, Sacchi L, Dagliati A, Marini S, Tibollo V, De Cata P, Bellazzi R, Chiovato L.

Diab Vasc Dis Res. 2018 Jun 1:1479164118780808. doi: 10.1177/1479164118780808. [Epub ahead of print]

PMID:
29911415
5.

Smartphone-Based Self-Management of Non-Insulin-Dependent Diabetes: A Japanese System at Use by an Italian Patients' Cohort.

Pinto S, Waki K, Chiovato L, De Cata P, Dagliati A, Tibollo V, Ruvolo G, Bellazzi R.

J Diabetes Sci Technol. 2018 Jul;12(4):903-904. doi: 10.1177/1932296818763884. Epub 2018 Apr 10. No abstract available.

PMID:
29633857
6.

2018 European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dysfunction.

Bartalena L, Bogazzi F, Chiovato L, Hubalewska-Dydejczyk A, Links TP, Vanderpump M.

Eur Thyroid J. 2018 Mar;7(2):55-66. doi: 10.1159/000486957. Epub 2018 Feb 14.

7.

Post-partum and non-post-partum relapsing Graves' hyperthyroidism display different response to anti-thyroid drugs.

Rotondi M, Capelli V, Coperchini F, Pinto S, Croce L, Tonacchera M, Chiovato L.

Eur J Endocrinol. 2018 Jun;178(6):589-594. doi: 10.1530/EJE-17-1063. Epub 2018 Mar 20.

PMID:
29559498
8.

The AMPK-activator AICAR in thyroid cancer: effects on CXCL8 secretion and on CXCL8-induced neoplastic cell migration.

Awwad O, Coperchini F, Pignatti P, Denegri M, Massara S, Croce L, Di Buduo CA, Abbonante V, Balduini A, Chiovato L, Rotondi M.

J Endocrinol Invest. 2018 Mar 15. doi: 10.1007/s40618-018-0862-8. [Epub ahead of print]

PMID:
29546654
9.

Careflow Mining Techniques to Explore Type 2 Diabetes Evolution.

Dagliati A, Tibollo V, Cogni G, Chiovato L, Bellazzi R, Sacchi L.

J Diabetes Sci Technol. 2018 Mar;12(2):251-259. doi: 10.1177/1932296818761751.

PMID:
29493360
10.

Effect of Thyroglobulin Autoantibodies on the Metabolic Clearance of Serum Thyroglobulin.

Latrofa F, Ricci D, Bottai S, Brozzi F, Chiovato L, Piaggi P, Marinò M, Vitti P.

Thyroid. 2018 Mar;28(3):288-294. doi: 10.1089/thy.2017.0052.

PMID:
29439614
11.

A dashboard-based system for supporting diabetes care.

Dagliati A, Sacchi L, Tibollo V, Cogni G, Teliti M, Martinez-Millana A, Traver V, Segagni D, Posada J, Ottaviano M, Fico G, Arredondo MT, De Cata P, Chiovato L, Bellazzi R.

J Am Med Inform Assoc. 2018 May 1;25(5):538-547. doi: 10.1093/jamia/ocx159.

PMID:
29409033
12.

Disabling portosystemic encephalopathy in a non-cirrhotic patient: Successful endovascular treatment of a giant inferior mesenteric-caval shunt via the left internal iliac vein.

de Martinis L, Groppelli G, Corti R, Moramarco LP, Quaretti P, De Cata P, Rotondi M, Chiovato L.

World J Gastroenterol. 2017 Dec 21;23(47):8426-8431. doi: 10.3748/wjg.v23.i47.8426.

13.

Autoimmune Thyroid Diseases in Patients Treated with Alemtuzumab for Multiple Sclerosis: An Example of Selective Anti-TSH-Receptor Immune Response.

Rotondi M, Molteni M, Leporati P, Capelli V, Marinò M, Chiovato L.

Front Endocrinol (Lausanne). 2017 Sep 28;8:254. doi: 10.3389/fendo.2017.00254. eCollection 2017. Review.

14.

Lipodystrophy and obesity are associated with decreased number of T cells with regulatory function and pro-inflammatory macrophage phenotype.

Berger S, Ceccarini G, Scabia G, Barone I, Pelosini C, Ferrari F, Magno S, Dattilo A, Chiovato L, Vitti P, Santini F, Maffei M.

Int J Obes (Lond). 2017 Nov;41(11):1676-1684. doi: 10.1038/ijo.2017.163. Epub 2017 Jul 10.

PMID:
28761130
15.

Selenium in the Treatment of Thyroid Diseases.

Marinò M, Marcocci C, Vitti P, Chiovato L, Bartalena L.

Eur Thyroid J. 2017 Apr;6(2):113-114. doi: 10.1159/000456660. Epub 2017 Mar 1. No abstract available.

16.

MR Micro-Neurography and a Segmentation Protocol Applied to Diabetic Neuropathy.

Felisaz PF, Maugeri G, Busi V, Vitale R, Balducci F, Gitto S, Leporati P, Pichiecchio A, Baldi M, Calliada F, Chiovato L, Bastianello S.

Radiol Res Pract. 2017;2017:2761818. doi: 10.1155/2017/2761818. Epub 2017 Apr 16.

17.

Machine Learning Methods to Predict Diabetes Complications.

Dagliati A, Marini S, Sacchi L, Cogni G, Teliti M, Tibollo V, De Cata P, Chiovato L, Bellazzi R.

J Diabetes Sci Technol. 2018 Mar;12(2):295-302. doi: 10.1177/1932296817706375. Epub 2017 May 12.

18.

Painful Hashimoto's thyroiditis: myth or reality?

Rotondi M, Capelli V, Locantore P, Pontecorvi A, Chiovato L.

J Endocrinol Invest. 2017 Aug;40(8):815-818. doi: 10.1007/s40618-017-0655-5. Epub 2017 Mar 24. Review.

PMID:
28337674
19.

Hierarchical Bayesian Logistic Regression to forecast metabolic control in type 2 DM patients.

Dagliati A, Malovini A, Decata P, Cogni G, Teliti M, Sacchi L, Cerra C, Chiovato L, Bellazzi R.

AMIA Annu Symp Proc. 2017 Feb 10;2016:470-479. eCollection 2016.

20.

Thyroid disruption by perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA).

Coperchini F, Awwad O, Rotondi M, Santini F, Imbriani M, Chiovato L.

J Endocrinol Invest. 2017 Feb;40(2):105-121. doi: 10.1007/s40618-016-0572-z. Epub 2016 Nov 11. Review.

PMID:
27837466
21.

Normal human thyroid cells, BCPAP, and TPC-1 thyroid tumor cell lines display different profile in both basal and TNF-α-induced CXCL8 secretion.

Coperchini F, Pignatti P, Leporati P, Carbone A, Croce L, Magri F, Chiovato L, Rotondi M.

Endocrine. 2016 Oct;54(1):123-128. Epub 2015 Oct 8.

PMID:
26450713
22.

Influence of short-term selenium supplementation on the natural course of Hashimoto's thyroiditis: clinical results of a blinded placebo-controlled randomized prospective trial.

Esposito D, Rotondi M, Accardo G, Vallone G, Conzo G, Docimo G, Selvaggi F, Cappelli C, Chiovato L, Giugliano D, Pasquali D.

J Endocrinol Invest. 2017 Jan;40(1):83-89. doi: 10.1007/s40618-016-0535-4. Epub 2016 Aug 29.

PMID:
27572248
23.

Effect of Interferon-γ on the Basal and the TNFα-Stimulated Secretion of CXCL8 in Thyroid Cancer Cell Lines Bearing Either the RET/PTC Rearrangement Or the BRAF V600e Mutation.

Rotondi M, Coperchini F, Awwad O, Pignatti P, Di Buduo CA, Abbonante V, Magri F, Balduini A, Chiovato L.

Mediators Inflamm. 2016;2016:8512417. doi: 10.1155/2016/8512417. Epub 2016 Jul 31.

24.

GENDER INFLUENCES THE CLINICAL PRESENTATION AND LONG-TERM OUTCOME OF GRAVES DISEASE.

Magri F, Zerbini F, Gaiti M, Capelli V, Ragni A, Rotondi M, Chiovato L.

Endocr Pract. 2016 Nov;22(11):1336-1342. Epub 2016 Aug 19.

PMID:
27540885
25.

Obesity Does Not Modify the Risk of Differentiated Thyroid Cancer in a Cytological Series of Thyroid Nodules.

Rotondi M, Castagna MG, Cappelli C, Ciuoli C, Coperchini F, Chiofalo F, Maino F, Palmitesta P, Chiovato L, Pacini F.

Eur Thyroid J. 2016 Jul;5(2):125-31. doi: 10.1159/000445054. Epub 2016 Apr 27.

26.

Recommendations for treatment of hypothyroidism with levothyroxine and levotriiodothyronine: a 2016 position statement of the Italian Society of Endocrinology and the Italian Thyroid Association.

Biondi B, Bartalena L, Chiovato L, Lenzi A, Mariotti S, Pacini F, Pontecorvi A, Vitti P, Trimarchi F.

J Endocrinol Invest. 2016 Dec;39(12):1465-1474. Epub 2016 Jul 29.

PMID:
27473077
27.

The phenotype of newly diagnosed Graves' disease in Italy in recent years is milder than in the past: results of a large observational longitudinal study.

Bartalena L, Masiello E, Magri F, Veronesi G, Bianconi E, Zerbini F, Gaiti M, Spreafico E, Gallo D, Premoli P, Piantanida E, Tanda ML, Ferrario M, Vitti P, Chiovato L.

J Endocrinol Invest. 2016 Dec;39(12):1445-1451. Epub 2016 Jul 27.

PMID:
27465670
28.

The role of elastography in thyroid ultrasonography.

Magri F, Chytiris S, Chiovato L.

Curr Opin Endocrinol Diabetes Obes. 2016 Oct;23(5):416-22. doi: 10.1097/MED.0000000000000274. Review.

PMID:
27428520
29.

Management of hyperthyroidism due to Graves' disease: frequently asked questions and answers (if any).

Bartalena L, Chiovato L, Vitti P.

J Endocrinol Invest. 2016 Oct;39(10):1105-14. doi: 10.1007/s40618-016-0505-x. Epub 2016 Jun 18. Review.

PMID:
27319009
30.

Migration flows affect women's dietary iodine intake and jeopardize their iodine sufficiency: a pilot study.

Magri F, Zerbini F, Gaiti M, Capelli V, Rotondi M, Ibañez MM, Chiovato L.

Endocrine. 2017 Apr;56(1):205-207. doi: 10.1007/s12020-016-0935-4. Epub 2016 Mar 26. No abstract available.

PMID:
27017338
31.

Improving risk-stratification of Diabetes complications using temporal data mining.

Sacchi L, Dagliati A, Segagni D, Leporati P, Chiovato L, Bellazzi R.

Conf Proc IEEE Eng Med Biol Soc. 2015;2015:2131-4. doi: 10.1109/EMBC.2015.7318810.

PMID:
26736710
32.

Template for preparation of papers for IEEE sponsored conferences & symposia.

Sacchi L, Dagliati A, Tibollo V, Leporati P, De Cata P, Cerra C, Chiovato L, Bellazzi R.

Conf Proc IEEE Eng Med Biol Soc. 2015;2015:2123-6. doi: 10.1109/EMBC.2015.7318808.

PMID:
26736708
33.

Integration of Administrative, Clinical, and Environmental Data to Support the Management of Type 2 Diabetes Mellitus: From Satellites to Clinical Care.

Dagliati A, Marinoni A, Cerra C, Decata P, Chiovato L, Gamba P, Bellazzi R.

J Diabetes Sci Technol. 2015 Dec 1;10(1):19-26. doi: 10.1177/1932296815619180.

34.

TNF-α increases the membrane expression of the chemokine receptor CCR6 in thyroid tumor cells, but not in normal thyrocytes: potential role in the metastatic spread of thyroid cancer.

Coperchini F, Pignatti P, Carbone A, Bongianino R, Di Buduo CA, Leporati P, Croce L, Magri F, Balduini A, Chiovato L, Rotondi M.

Tumour Biol. 2016 Apr;37(4):5569-75. doi: 10.1007/s13277-015-4418-7. Epub 2015 Nov 17.

PMID:
26577851
35.

Anti-Mullerian hormone as a predictor of ovarian reserve in ART protocols: the hidden role of thyroid autoimmunity.

Magri F, Schena L, Capelli V, Gaiti M, Zerbini F, Brambilla E, Rotondi M, De Amici M, Spinillo A, Nappi RE, Chiovato L.

Reprod Biol Endocrinol. 2015 Sep 21;13(1):106. doi: 10.1186/s12958-015-0103-3.

36.

Etiopathogenesis of Basedow's disease. Trends and current aspects.

Leporati P, Groppelli G, Zerbini F, Rotondi M, Chiovato L.

Nuklearmedizin. 2015;54(5):204-10. doi: 10.3413/Nukmed-0739-15-04. Epub 2015 Aug 21. Review.

PMID:
26293122
37.

Improving Clinical Decisions on T2DM Patients Integrating Clinical, Administrative and Environmental Data.

Segagni D, Sacchi L, Dagliati A, Tibollo V, Leporati P, De Cata P, Chiovato L, Bellazzi R.

Stud Health Technol Inform. 2015;216:682-6.

PMID:
26262138
38.

Expanding the therapeutic spectrum of metformin: from diabetes to cancer.

Coperchini F, Leporati P, Rotondi M, Chiovato L.

J Endocrinol Invest. 2015 Oct;38(10):1047-55. doi: 10.1007/s40618-015-0370-z. Epub 2015 Aug 2. Review.

PMID:
26233338
39.

A male patient with acromegaly and breast cancer: treating acromegaly to control tumor progression.

Leporati P, Fonte R, de Martinis L, Zambelli A, Magri F, Pavesi L, Rotondi M, Chiovato L.

BMC Cancer. 2015 May 12;15:397. doi: 10.1186/s12885-015-1400-0.

40.

Pregnancy outcome in women treated with methimazole or propylthiouracil during pregnancy.

Gianetti E, Russo L, Orlandi F, Chiovato L, Giusti M, Benvenga S, Moleti M, Vermiglio F, Macchia PE, Vitale M, Regalbuto C, Centanni M, Martino E, Vitti P, Tonacchera M.

J Endocrinol Invest. 2015 Sep;38(9):977-85. doi: 10.1007/s40618-015-0281-z. Epub 2015 Apr 4.

PMID:
25840794
41.

Maternal hypothyroidism and subsequent neuropsychological outcome of the progeny: a family portrait.

Pasquali D, Carotenuto M, Leporati P, Esposito M, Antinolfi L, Esposito D, Accardo G, Carella C, Chiovato L, Rotondi M.

Endocrine. 2015 Dec;50(3):797-801. doi: 10.1007/s12020-015-0564-3. Epub 2015 Mar 6. No abstract available.

PMID:
25743264
42.

Maximal stiffness evaluation by real-time ultrasound elastography, an improved tool for the differential diagnosis of thyroid nodules.

Magri F, Chytiris S, Zerbini F, Capelli V, Gaiti M, Carbone A, Fonte R, Malovini A, Rotondi M, Bellazzi R, Chiovato L.

Endocr Pract. 2015 May;21(5):474-81. doi: 10.4158/EP14504.OR. Epub 2015 Feb 9.

PMID:
25667375
43.

Metformin reverts the secretion of CXCL8 induced by TNF-α in primary cultures of human thyroid cells: an additional indirect anti-tumor effect of the drug.

Rotondi M, Coperchini F, Pignatti P, Magri F, Chiovato L.

J Clin Endocrinol Metab. 2015 Mar;100(3):E427-32. doi: 10.1210/jc.2014-3045. Epub 2015 Jan 15.

PMID:
25590211
44.

Role of genetic and non-genetic factors in the etiology of Graves' disease.

Marinò M, Latrofa F, Menconi F, Chiovato L, Vitti P.

J Endocrinol Invest. 2015 Mar;38(3):283-94. doi: 10.1007/s40618-014-0214-2. Epub 2014 Nov 25. Review.

PMID:
25421156
45.

ER-alpha and ER-beta expression in differentiated thyroid cancer: relation with tumor phenotype across the TNM staging and peri-tumor inflammation.

Magri F, Capelli V, Gaiti M, Villani L, Zerbini F, La Manna L, Rotondi M, Chiovato L.

Endocrine. 2015 Jun;49(2):429-35. doi: 10.1007/s12020-014-0457-x. Epub 2014 Oct 22.

PMID:
25338203
46.

Mechanisms in endocrinology: the crosstalk between thyroid gland and adipose tissue: signal integration in health and disease.

Santini F, Marzullo P, Rotondi M, Ceccarini G, Pagano L, Ippolito S, Chiovato L, Biondi B.

Eur J Endocrinol. 2014 Oct;171(4):R137-52. doi: 10.1530/EJE-14-0067. Review.

47.

Graves'-like orbitopathy: do not forget IgG4-related disease.

Bartalena L, Chiovato L.

J Endocrinol Invest. 2014 Dec;37(12):1233-5. doi: 10.1007/s40618-014-0171-9. Epub 2014 Sep 7. Review. No abstract available.

PMID:
25194429
48.

An update on the medical treatment of Graves' hyperthyroidism.

Marinò M, Latrofa F, Menconi F, Chiovato L, Vitti P.

J Endocrinol Invest. 2014 Nov;37(11):1041-8. doi: 10.1007/s40618-014-0136-z. Epub 2014 Sep 4. Review.

PMID:
25185644
49.

Exposure to perfluorinated compounds: in vitro study on thyroid cells.

Coperchini F, Pignatti P, Lacerenza S, Negri S, Sideri R, Testoni C, de Martinis L, Cottica D, Magri F, Imbriani M, Rotondi M, Chiovato L.

Environ Sci Pollut Res Int. 2015 Feb;22(3):2287-94. doi: 10.1007/s11356-014-3480-9. Epub 2014 Sep 4.

PMID:
25182428
50.

Thyroglobulin autoantibodies as surrogate biomarkers in the management of patients with differentiated thyroid carcinoma.

Feldt-Rasmussen U, Verburg FA, Luster M, Cupini C, Chiovato L, Duntas L, Elisei R, Rimmele H, Seregni E, Smit JW, Theimer C, Giovanella L.

Curr Med Chem. 2014;21(32):3687-92. Review.

PMID:
25174917

Supplemental Content

Loading ...
Support Center